(Q34576250)

3 August 2017

1 reference

title

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder (English)

1 reference

3 August 2017

1 reference

K N Chengappa

1

1 reference

3 August 2017

S Gershon

series ordinal

2

1 reference

3 August 2017

J Levine

series ordinal

3

1 reference

3 August 2017

publication date

1 October 2001

1 reference

3 August 2017

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

215-232

1 reference

Forty years of lithium treatment

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Mood stabilizer combinations: a review of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Anti-bipolar therapy: mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Low plasma GABA is a trait-like marker for bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

GABA and mood disorders: a brief review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Cation transport in lymphoblastoid cell lines established from bipolar manic-depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Sodium currents in isolated rat CA1 neurons after kindling epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Changes in voltage-dependent calcium channel alpha1-subunit mRNA levels in the kindling model of epileptogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Calcium currents in pyramidal CA1 neurons in vitro after kindling epileptogenesis in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Topiramate increases cerebral GABA in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Beyond lithium in the treatment of bipolar illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

A pilot study of topiramate as monotherapy in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Use of topiramate, a new anti-epileptic as a mood stabilizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Mood stabilization and weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Carbamazepine plasma concentration. Relationship to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

Predictors of response to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Carbamazepine compared to haloperidol in acute mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Long-term prophylactic effects of carbamazepine in affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Carbamazepine compared with lithium in the treatment of mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Treatment of acute bipolar depression: a review of the literature

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Loss of long-lasting potentiation mediated by group III mGluRs in amygdala neurons in kindling-induced epileptogenesis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Erythrocyte sodium pump activity in bipolar affective disorder and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Topiramate blocks kainate-evoked cobalt influx into cultured neurons

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Acetazolamide in bipolar affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Acetazolamide in the Treatment of Acute Mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Topiramate as add-on treatment for patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Cognitive effects of valproate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Withdrawal of phenobarbital and carbamazepine in epileptic patients: a preliminary neuropsychological report.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30501.X

7 January 2021

10.1034/J.1399-5618.2001.30501.X

Identifiers

DOI

1 reference

3 August 2017

1 reference